logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Maternal & Neonatal Health drugs

    FiltersReset Filters
    16 results

    • bijuva

      (estradiol and progesterone)
      Mayne Pharma LLC
      Usage: The drug is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause.

    • bonjesta

      (doxylamine succinate and pyridoxine hydrochloride)
      Duchesnay USA, Inc.
      Usage: BONJESTA is indicated for treating nausea and vomiting of pregnancy in women unresponsive to conservative measures. It has not been studied for hyperemesis gravidarum.

    • kyleena

      (Levonorgestrel)
      Bayer HealthCare Pharmaceuticals Inc.
      Usage: Kyleena is indicated for the prevention of pregnancy for up to 5 years. If continued use is desired, the device should be replaced after 5 years.

    • liletta

      (Levonorgestrel)
      Allergan, Inc.
      Usage: LILETTA is indicated for contraception to prevent pregnancy for up to 8 years and for the treatment of heavy menstrual bleeding for up to 5 years in patients using intrauterine contraception, with replacement required after 5 years if continued treatment is necessary.

    • lo loestrin fe

      (norethindrone acetate and ethinyl estradiol, ethinyl estradiol and ferrous fumarate)
      Allergan, Inc.
      Usage: Lo Loestrin® Fe is indicated for the prevention of pregnancy in women. Its efficacy in women with a BMI greater than 35 kg/m² has not been evaluated.

    • lupron depot

      (leuprolide acetate)
      AbbVie Inc.
      Usage: LUPRON DEPOT 11.25 mg is indicated for managing endometriosis, including pain relief and lesion reduction, as well as for preoperative anemia improvement in women with uterine leiomyomata (fibroids), used with iron therapy. It is not meant for prolonged use or specific combinations beyond stated limits.

    • mirena

      (Levonorgestrel)
      Bayer HealthCare Pharmaceuticals Inc.
      Usage: Mirena is indicated for contraception, preventing pregnancy for up to 8 years, and for treating heavy menstrual bleeding for up to 5 years in women using it as their contraceptive method. Replacement is suggested at the end of the respective durations if treatment continues.

    • myobloc

      (rimabotulinumtoxinB)
      Solstice Neurosciences, LLC
      Usage: MYOBLOC is indicated for treating cervical dystonia in adults to reduce abnormal head position and neck pain, and for the treatment of chronic sialorrhea in adults.

    • natazia

      (estradiol valerate and estradiol valerate/dienogest)
      Bayer HealthCare Pharmaceuticals Inc.
      Usage: Natazia® is indicated for preventing pregnancy in women and for treating heavy menstrual bleeding in those without organic pathology who prefer an oral contraceptive. Efficacy in women with a BMI over 30 kg/m² has not been evaluated.

    • nexplanon

      (etonogestrel)
      Organon LLC
      Usage: NEXPLANON® is indicated for use in women to prevent pregnancy.